Skip to main content
1238 search results for:

Rheumatoid arthritis 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 15-09-2022 | Rheumatoid arthritis | Adis Journal Club | Article
    Drugs & Aging

    Difficult-to-Treat Rheumatoid Arthritis in Older Adults: Implications of Ageing for Managing Patients

    The management of an older rheumatoid arthritis population requires special care in drug selection and dose adjustments to ensure adequate treatment.

  2. 18-07-2022 | Rheumatoid arthritis | Adis Journal Club | Article
    Rheumatology and Therapy

    Artificial Intelligence in Rheumatoid Arthritis: Current Status and Future Perspectives: A State-of-the-Art Review

    DOI [Teaser] Key Summary Points Rheumatoid arthritis (RA) is among the most common rheumatologic diseases.

  3. 02-05-2022 | Rheumatoid arthritis | Adis Journal Club | Article
    Rheumatology and Therapy

    Abnormalities of Peripheral Lymphocyte Subsets in Rheumatoid Arthritis Patients Complicated with Osteoporosis

    Authors: Ting Cheng, Sheng-Xiao Zhang, Jia Wang, Jun Qiao, Min-Jing Chang, Hong-Qing Niu, Guang-Ying Liu & Xiao-Feng Li Abstract Introduction Osteoporosis (OP) is one of the major comorbidities of rheumatoid arthritis (RA).

  4. 28-03-2022 | Rheumatoid arthritis | Adis Journal Club | Article
    Rheumatology and Therapy

    Towards a Better Implementation of Treat-to-Target Strategy in Rheumatoid Arthritis: A Comparison of Two Real-World Cohorts

    The treat-to-target (T2T) strategy has substantially improved the prognosis of patients with rheumatoid arthritis (RA).

  5. 06-12-2021 | Infection | Adis Journal Club | Article
    Rheumatology and Therapy

    Clinical Management of Herpes Zoster in Patients With Rheumatoid Arthritis or Psoriatic Arthritis Receiving Tofacitinib Treatment

    We evaluated clinical study data relating to HZ management in patients with rheumatoid arthritis (RA) or psoriatic arthritis (PsA) receiving tofacitinib.

  6. 08-02-2022 | Rheumatoid arthritis | Adis Journal Club | Article
    Rheumatology and Therapy

    Anti-TNF Induced Sarcoidosis-Like Disease in Rheumatoid Arthritis Patients: Review Cases from the RA UCLouvain Brussels Cohort

    Authors: Xavier Theunssens, Laura Bricman, Stéphanie Dierckx, Emilie Sapart, Tatiana Sokolova, Aleksandra Avramovska & Patrick Durez Abstract Introduction Drug-induced sarcoidosis-like disease is a rare side effect of anti-tumor necrosis factor (anti-TNF) agents in rheumatoid arthritis (RA) patients.

  7. 08-01-2022 | Total hip replacement | Adis Journal Club | Article
    Rheumatology and Therapy

    Total Hip Replacement in Patients with Rheumatoid Arthritis: Trends in Incidence and Complication Rates Over 35 Years

    Nossen Abstract Introduction Advances in rheumatoid arthritis (RA) management have made disease remission achievable.

  8. 14-09-2021 | Psoriatic arthritis | Adis Journal Club | Article
    Rheumatology and Therapy

    Differentiating Psoriatic Arthritis from Osteoarthritis and Rheumatoid Arthritis: A Narrative Review and Guide for Advanced Practice Providers

    PsA is frequently undiagnosed and/or misdiagnosed, especially because of the similarities in clinical presentation shared with other arthritic diseases, including rheumatoid arthritis (RA) and osteoarthritis (OA).

  9. 13-12-2021 | Mental health | Adis Journal Club | Article
    Rheumatology and Therapy

    Association Between Janus Kinase Inhibitors Therapy and Mental Health Outcome in Rheumatoid Arthritis: A Systematic Review and Meta-analysis

    From individual trials, each JAK inhibitor, separately had an impact on the mental health in patients with rheumatoid arthritis, but the synthesized result was limited.

  10. 25-07-2021 | Rheumatoid arthritis | Adis Journal Club | Article
    Clinical Drug Investigation

    Filgotinib in Rheumatoid Arthritis: A Profile of Its Use

    Keam Abstract Filgotinib (Jyseleca®), an oral Janus kinase (JAK) inhibitor, is approved as monotherapy or in combination with methotrexate to treat moderate to severe active rheumatoid arthritis (RA) in adults who have an inadequate response or intolerance to one or more disease-modifying antirheumatic drugs (DMARDs).

  11. 08-12-2021 | Rheumatoid arthritis | Adis Journal Club | Article
    Rheumatology and Therapy

    Differential Changes in ACPA Fine Specificity and Gene Expression in a Randomized Trial of Abatacept and Adalimumab in Rheumatoid Arthritis

    We analyzed data from patients with rheumatoid arthritis treated in AMPLE (NCT00929864) to explore the pharmacodynamic effects of abatacept or adalimumab on anti-citrullinated protein antibodies (ACPAs) and gene expression.

  12. 23-11-2021 | Upadacitinib | Adis Journal Club | Article
    Rheumatology and Therapy

    Benefit–Risk Analysis of Upadacitinib Compared with Adalimumab in the Treatment of Patients with Moderate-to-Severe Rheumatoid Arthritis

    Betts, Pankaj Patel, Jianzhong Liu, Rochelle Sun & Roy Fleischmann Abstract Introduction Rheumatoid arthritis (RA) is a chronic autoimmune disease requiring long-term treatment.

  13. 06-09-2021 | Rheumatoid arthritis | Adis Journal Club | Article
    The Patient - Patient-Centered Outcomes Research

    Adaptation of a Shared Decision-Making Tool for Early Rheumatoid Arthritis Treatment Decisions with Indigenous Patients

    Our objective was to adapt the Early RA (rheumatoid arthritis) PtDA for use with Canadian Indigenous patients.

  14. 15-06-2021 | Rheumatoid arthritis | News | Article
    guidelinesWatch

    ACR issues guidelines for rheumatoid arthritis treatment

    medwireNews : The American College of Rheumatology has released updated guidelines for the pharmacologic treatment of rheumatoid arthritis (RA).

  15. 27-08-2021 | Rheumatoid arthritis | Adis Journal Club | Article
    PharmacoEconomics

    Filgotinib for Moderate to Severe Rheumatoid Arthritis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

    DOI [Teaser] Key Points for Decision Makers Filgotinib is the first biological disease-modifying antirheumatic drug (DMARD) that has been recommended for use in patients with moderate rheumatoid arthritis (RA) in the England and Wales National Health Service.

  16. 18-06-2021 | Adis Journal Club | Article
    The Patient - Patient-Centered Outcomes Research

    Towards Personalising the Use of Biologics in Rheumatoid Arthritis: A Discrete Choice Experiment

    DOI [Teaser] Key Points for Decision Makers A growing body of research is investigating how rheumatoid arthritis treatments such as biologics may be targeted to those who would benefit the most.

  17. 30-04-2021 | Rheumatoid arthritis | News | Article

    Clinical differences in baricitinib and tofacitinib effectiveness in rheumatoid arthritis

    Patients with rheumatoid arthritis may derive better clinical outcomes from baricitinib than tofacitinib in the first 24 weeks of treatment, especially if they have previously received multiple biologic DMARDs, show real-world data.

  18. 23-07-2021 | Adis Journal Club | Article
    Rheumatology and Therapy

    TNF-α Blockers Showed Prophylactic Effects in Preventing COVID-19 in Patients with Rheumatoid Arthritis and Seronegative Spondyloarthropathies: A Case–Control Study

    TNF-α blockers are prescribed to treat various autoimmune disorders, including rheumatoid arthritis (RA) and seronegative spondyloarthropathies (SpA).

  19. 26-04-2021 | BSR 2021 | Conference coverage | Article
    News in brief

    Age, sex may influence baricitinib discontinuation rates in rheumatoid arthritis

    Real-world study results suggest that the majority of baricitinib-treated patients with rheumatoid arthritis remain on the JAK inhibitor after a year, with older age and female sex associated with treatment persistence.

  20. 12-04-2021 | Rheumatoid arthritis | News | Article

    Similar rheumatoid arthritis outcomes with oral vs subcutaneous methotrexate

    Real-world study results suggest that patients with rheumatoid arthritis who initiate treatment with oral methotrexate achieve similar disease control to those taking the subcutaneous formulation.

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.